The Global Biobanking Market Report, published by Emergen Research, offers an industry-wide assessment of the Biobanking Market, which is inclusive of the most crucial factors contributing to the growth of the industry. The latest research report comprises an extensive analysis of the micro- and macro-economic indicators that influence the global market development during the forecast period of 2022-2030.
The global biobanking market size is expected to reach USD 67.90 Billion in 2030 and register a revenue CAGR of 8.6% over the forecast period. Increasing genomic research activities and investment in RD by major companies is driving global biobanking market revenue growth. Surge in research activities of regenerative medicines, stem cell therapeutics, and cell and gene therapy is also driving revenue growth of the global market.
Biobanking market revenue growth is also driven by increase in application of bio-banked samples. Biobanks focusing on plants, animals, and microbes are evolving rapidly. Different types of biobanks are gaining traction, such as disease-centric biobanks, population-based banks, DNA/RNA banks, genetic banks, tissue banks, blood banks, virtual biobanks, stem cell banks, microbiome banks, and others, which is driving market revenue growth. Biobanks enable access to large pool of high-quality samples and associated data. These are reliable hubs for storage and processing of samples from clinical trials and other sources. Biobanks help to achieve important conditions for achieving reproducible research results.
Get a sample of the report @ https://www.emergenresearch.com/request-sample/926
The section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Biobanking market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.
Key players in the market include K. Biobank Limited, Medizinische Universitat Graz, Hamilton Company, ASKION, Azenta Life Sciences, Qiagen, Promega Corporation, Integrated Biobank of Luxembourg (IBBL), Isenet Biobanking, and Thermo Fisher Scientific, Inc.
To know more about the report @ https://www.emergenresearch.com/industry-report/biobanking-market
Emergen Research has segmented the global biobanking market on the basis of product services, sample type, storage type, application, and region:
Product Services Outlook (Revenue, USD Billion; 2018–2030)
Equipment
Storage Equipment
Sample Transport Equipment
Sample Processing Equipment
Sample Analysis Equipment
Consumables
Collection Consumables
Storage Consumables
Processing Consumables
Analysis Consumables
Services
Supply Services
Processing Services
Storage Services
Transport Services
Software
Sample Type Outlook (Revenue, USD Billion; 2018–2030)
Biological Fluids
Human Tissues
Blood Products
Nucleic Acids
Human Waste Products
Cell Lines
Storage Type Outlook (Revenue, USD Billion; 2018–2030)
Automated Storage
Manual Storage
Application Outlook (Revenue, USD Billion; 2018–2030)
Regenerative Medicine
Life Science Research
Clinical Research
Request a discount on the report @ https://www.emergenresearch.com/request-discount/926
Regional Analysis Covers:
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Research Report on the Biobanking Market Addresses the Following Key Questions:
Who are the dominant players of the Biobanking market?
Which regional market is anticipated to have a high growth rate over the projected period?
What consumer trends and demands are expected to influence the operations of the market players in the Biobanking market?
What are the key growth drivers and restraining factors of the Biobanking market?
What are the expansion plans and strategic investment plans undertaken by the players to gain a robust footing in the market?
What is the overall impact of the COVID-19 pandemic on the Biobanking market and its key segments?
Request a customization of the report @ https://www.emergenresearch.com/request-for-customization/926
Thank you for reading the research report. To get more information about the customized report and customization plan, kindly connect to us and we will provide you with the well-suited customized report.
Take a Look at our other Reports:
http://www.v-degunino.ru/url.php?http://emergenresearch.com
About Us:
At Emergen Research, we believe in advancing with technology. We are growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkedIn | Twitter | Blogs
Latest Reports: Aircraft Sensors Market, Natural Language Processing Market
Trending Reports: Electric Vehicle Car Polymers Market, Postpartum Depression Market
Read Full Press Release @ https://www.emergenresearch.com/press-release/global-biobanking-market
